BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29376112)

  • 1. Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial.
    de Alarcon PA; Matthay KK; London WB; Naranjo A; Tenney SC; Panzer JA; Hogarty MD; Park JR; Maris JM; Cohn SL
    Lancet Child Adolesc Health; 2018 Jan; 2(1):25-34. PubMed ID: 29376112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.
    Kumar P; Willard VW; Embry L; Naranjo A; LaBarre B; Matthay KK; de Alarcon PA
    Pediatr Blood Cancer; 2024 Jul; 71(7):e31039. PubMed ID: 38689540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae.
    Mitchell WG; Davalos-Gonzalez Y; Brumm VL; Aller SK; Burger E; Turkel SB; Borchert MS; Hollar S; Padilla S
    Pediatrics; 2002 Jan; 109(1):86-98. PubMed ID: 11773546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late presentation of opsoclonus-myoclonus-ataxia syndrome in a child with stage 4S neuroblastoma.
    Mutch LS; Johnston DL
    J Pediatr Hematol Oncol; 2005 Jun; 27(6):341-3. PubMed ID: 15956891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsoclonus-Myoclonus Syndrome: A New Era of Improved Prognosis?
    Galstyan A; Wilbur C; Selby K; Hukin J
    Pediatr Neurol; 2017 Jul; 72():65-69. PubMed ID: 28479124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.
    Rudnick E; Khakoo Y; Antunes NL; Seeger RC; Brodeur GM; Shimada H; Gerbing RB; Stram DO; Matthay KK
    Med Pediatr Oncol; 2001 Jun; 36(6):612-22. PubMed ID: 11344492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome.
    De Grandis E; Parodi S; Conte M; Angelini P; Battaglia F; Gandolfo C; Pessagno A; Pistoia V; Mitchell WG; Pike M; Haupt R; Veneselli E
    Neuropediatrics; 2009 Jun; 40(3):103-11. PubMed ID: 20020394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroblastoma With Opsoclonus-Myoclonus-Ataxia Syndrome: Role of Chemotherapy in the Management: Experience From a Tertiary Care Center in a Resource-limited Setting.
    Anand S; Agarwala S; Jain V; Bakhshi S; Dhua A; Gulati S; Seth R; Srinivas M; Jana M; Kandasamy D; Bhatnagar V
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e924-e929. PubMed ID: 33769388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.
    Patel A; Fischer C; Lin YC; Basu EM; Kushner BH; De Braganca K; Khakoo Y
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28319. PubMed ID: 32543116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ofatumumab for refractory opsoclonus-myoclonus syndrome following treatment of neuroblastoma.
    Ketterl TG; Messinger YH; Niess DR; Gilles E; Engel WK; Perkins JL
    Pediatr Blood Cancer; 2013 Dec; 60(12):E163-5. PubMed ID: 23813921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone, Intravenous Immunoglobulin, and Rituximab Combination Immunotherapy for Pediatric Opsoclonus-Myoclonus Syndrome.
    Pranzatelli MR; Tate ED
    Pediatr Neurol; 2017 Aug; 73():48-56. PubMed ID: 28651977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroblastoma and opsoclonus-myoclonus-ataxia syndrome--clinical and pathological characteristics.
    Stefanowicz J; Izycka-Swieszewska E; Drozyńska E; Pienczk J; Połczyńska K; Czauderna P; Sierota D; Bień E; Stachowicz-Stencel T; Kosiak W; Balcerska A
    Folia Neuropathol; 2008; 46(3):176-85. PubMed ID: 18825593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and prognostic analysis of opsoclonus-myoclonus-ataxia syndrome in children].
    Zhou J; Zhuo XW; Jin M; Duan C; Zhang WH; Ren CH; Gong S; Tian XJ; Ding CH; Ren XT; Li JW
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):256-261. PubMed ID: 38378288
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
    Zhao W; Sun Q; Xie Y; Hua Y; Xiong H; Jia J; Lu X
    Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):540-3. PubMed ID: 25224062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five Years Follow-up of Opsoclonus-Myoclonus-Ataxia Syndrome-Associated Neurogenic Tumors in Children.
    Aktekin EH; Gezer HÖ; Yazıcı N; Erol İ; Erbay A; Sarıalioğlu F
    Neuropediatrics; 2024 Feb; 55(1):57-62. PubMed ID: 37019145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists].
    Plantaz D; Michon J; Valteau-Couanet D; Coze C; Chastagner P; Bergeron C; Nelken B; Martelli H; Peyroulet MC; Carpentier AF; Armari-Alla C; Pagnier A; Rubie H
    Arch Pediatr; 2000 Jun; 7(6):621-8. PubMed ID: 10911528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to rituximab and prednisolone for opsoclonus-myoclonus-ataxia syndrome in a child with ganglioneuroblastoma.
    Corapcioglu F; Mutlu H; Kara B; Inan N; Akansel G; Gürbüz Y; Topcu S
    Pediatr Hematol Oncol; 2008 Dec; 25(8):756-61. PubMed ID: 19065442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group.
    Russo C; Cohn SL; Petruzzi MJ; de Alarcon PA
    Med Pediatr Oncol; 1997 Apr; 28(4):284-8. PubMed ID: 9078325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous stem cell transplantation for refractory opsoclonus myoclonus ataxia syndrome.
    Johnston DL; Murray S; Irwin MS; Doyle J; Schechter T
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27110. PubMed ID: 29693780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-related opsoclonus-myoclonus-ataxia syndrome: report on two cases.
    Kanjanasut N; Phanthumchinda K; Bhidayasiri R
    Clin Neurol Neurosurg; 2010 Sep; 112(7):572-4. PubMed ID: 20427123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.